Clinical Trial Update: Conventional Adjuvant Temozolomide With Dose Intensive Temozolomide in Patients With Newly Diagnosed Glioblastoma [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating conventional adjuvant temozolomide with dose-intensive temozolomide in newly diagnosed Glioblastoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Temozolomide (Temozolomide)

Snippet

Sponsor: King Faisal Specialist Hospital & Research Center | Conditions: Glioblastoma | Phase 3 | Status: COMPLETED